Skip to main content
Clinical Trials/IRCT20181201041812N1
IRCT20181201041812N1
Recruiting
Phase 3

Comparison of efficacy and safety of topical Hydroquinon with and without using fractional Erbium YAG LASER in treatment of melasma

Tehran University of Medical Sciences0 sites27 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Melasma.
Sponsor
Tehran University of Medical Sciences
Enrollment
27
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Symmetrical melasma in both half of the face
  • Patients satisfaction
  • Skin type 1\-3

Exclusion Criteria

  • Pregnancy or lactation
  • Use of alpha hydroxy acids and other drugs effect on pigmentation during past 4 weeks
  • Use of topical and oral retinoid
  • Use of topical steroid
  • Use of Oral Contraceptive Pills
  • Chemical peeling ,microderm abrasion, derm abrasion or LASER during past 3 months
  • History of keloid
  • History of past sensitivity to hydroquinon
  • History of thyroid dysfunction
  • LASER therapy in past 3 months

Outcomes

Primary Outcomes

Not specified

Similar Trials